Abstract:Cardiovascular diseases (CVDs) are complex, multifactorial conditions that require personalized assessment and treatment. Advancements in multi-omics technologies, namely RNA sequencing and whole-genome sequencing, have provided translational researchers with a comprehensive view of the human genome. The efficient synthesis and analysis of this data through integrated approach that characterizes genetic variants alongside expression patterns linked to emerging phenotypes, can reveal novel biomarkers and enable the segmentation of patient populations based on personalized risk factors. In this study, we present a cutting-edge methodology rooted in the integration of traditional bioinformatics, classical statistics, and multimodal machine learning techniques. Our approach has the potential to uncover the intricate mechanisms underlying CVD, enabling patient-specific risk and response profiling. We sourced transcriptomic expression data and single nucleotide polymorphisms (SNPs) from both CVD patients and healthy controls. By integrating these multi-omics datasets with clinical demographic information, we generated patient-specific profiles. Utilizing a robust feature selection approach, we identified a signature of 27 transcriptomic features and SNPs that are effective predictors of CVD. Differential expression analysis, combined with minimum redundancy maximum relevance feature selection, highlighted biomarkers that explain the disease phenotype. This approach prioritizes both biological relevance and efficiency in machine learning. We employed Combination Annotation Dependent Depletion scores and allele frequencies to identify variants with pathogenic characteristics in CVD patients. Classification models trained on this signature demonstrated high-accuracy predictions for CVD. The best performing of these models was an XGBoost classifier optimized via Bayesian hyperparameter tuning, which was able to correctly classify all patients in our test dataset. Using SHapley Additive exPlanations, we created risk assessments for patients, offering further contextualization of these predictions in a clinical setting. Across the cohort, RPL36AP37 and HBA1 were scored as the most important biomarkers for predicting CVDs. A comprehensive literature review revealed that a substantial portion of the diagnostic biomarkers identified have previously been associated with CVD. The framework we propose in this study is unbiased and generalizable to other diseases and disorders.

Multimodal mechanistic signatures for neurodegenerative diseases (NeuroMMSig): a web server for mechanism enrichment

Towards Prediction and Prioritization of Disease Genes by the Modularity of Human Phenome-Genome Assembled Network.

Network Integration and Protein Structural Binding Analysis of Neurodegeneration-Related Interactome.

Towards Identification of Human Disease Phenotype-Genotype Association via a Network-Module Based Method

MMCA: a Web-based Server for the Microbiome and Metabolome Correlation Analysis

Mergeomics: a web server for identifying pathological pathways, networks, and key regulators via multidimensional data integration

A coupled-mechanisms modelling framework for neurodegeneration

The Interpretable Multimodal Machine Learning (IMML) framework reveals pathological signatures of distal sensorimotor polyneuropathy

Integration of Biological Data via NMF for Identification of Human Disease-Associated Gene Modules through Multi-label Classification.

Beyond the usual suspects: multi-factorial computational models in the search for neurodegenerative disease mechanisms

MODalyseR-a novel software for inference of disease module hub regulators identified a putative multiple sclerosis regulator supported by independent eQTL data

Morbigenous Brain Region and Gene Detection with a Genetically Evolved Random Neural Network Cluster Approach in Late Mild Cognitive Impairment.

Using Multi-Scale Genetic, Neuroimaging and Clinical Data for Predicting Alzheimer’s Disease and Reconstruction of Relevant Biological Mechanisms

ANSH: Multimodal Neuroimaging Database Including MR Spectroscopic Data From Each Continent to Advance Alzheimer's Disease Research

Multimodal Neurodegenerative Disease Subtyping Explained by ChatGPT

Identifying Neuroimaging and Proteomic Biomarkers for MCI and AD Via the Elastic Net

Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight

Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease

Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway Model

Molecular imaging in early diagnosis, differential diagnosis and follow-up of patients with neurodegenerative diseases

Multimodal AI/ML for discovering novel biomarkers and predicting disease using multi-omics profiles of patients with cardiovascular diseases